Table 2.
Frequency of MMP-2 (-1306 C/T) genotype in the patients with pituitary adenoma (PA) and in the control group.
| Gene marker | Genotype/allele | Frequency (%) | ||||
|---|---|---|---|---|---|---|
| Control group n (%) (n = 318) |
p
HWE |
PA group n (%) (n = 84) |
p
HWE |
p value | ||
| MMP-2 (-1306) Rs243865 | Genotype | 0.383 | 0.390 | |||
| C/C | 190 (59.75) | 42 (50.00) | χ 2 = 2.980 | |||
| C/T | 108 (33.96) | 37 (44.00) | p = 0.225 | |||
| T/T | 20 (6.29) | 5 (6.00) | ||||
| Total | 318 (100) | 84 (100) | ||||
| Allele | ||||||
| C | 0.767 | 0.720 | ||||
| T | 0.233 | 0.280 | ||||
MMP: matrix metalloproteinase; p value: significance level (alfa = 0.05); p-value HWE: significance level (alfa = 0.05) by Hardy-Weinberg equilibrium.